Deals
Tempus, Groupon Co-Founder's Medical Technology Startup, Is Exploring an IPO
- Startup raised funding at $8.1 billion valuation last year
- Baillie Gifford, Franklin Templeton, Google are investors
This article is for subscribers only.
Tempus Labs Inc., a precision medicine startup led by a Groupon Inc. co-founder, is exploring a U.S. initial public offering, according to people with knowledge of the matter.
The Chicago-based company is considering a stock-market debut as soon as the first half of 2022, the people said, asking not to be identified discussing information that isn’t public. Plans could change and timing could shift, one of the people said.